News - Latest

1. Rates established for assessment of research under CTR and MDR

   The Ministry of Health, Welfare and Sport has set the rates for medical ethical review in the Netherlands of research under the ...

   News item | 17-09-2021 | 11:13

2. Clinical Trial Regulation (CTR) applicable from 31 January 2022, VHP concludes on 15 October 2021

   On 31 July, the European Commission has announced in the Official Journal of the European Union that the Clinical Trial ...

   News item | 04-08-2021 | 10:38

3. Site Suitability Declaration (VGO) as of 1 November 2021 obligatory for research with a medicinal product

   As of 1 November 2021, use of the Site Suitability Declaration [Verklaring Geschiktheid Onderzoeksinstelling, VGO] will become ...

   News item | 09-07-2021 | 14:55

4. Changes in CCMO's assessment task for specific types of research

   CCMO’s assessment task has been adapted for specific types of research. These adaptations have been laid down in the Dutch ...

   News item | 29-06-2021 | 16:36

5. Information EU Medical Device Regulation available on CCMO website

   On May 26, 2021, the EU Medical Device Regulation (EU no 2017/745, MDR) has come into effect. The MDR contains specific rules for ...

   News item | 24-06-2021 | 17:06

6. CCMO reviews research on cell therapy, gene therapy, other products that specifically influence the functioning of the genetic material and medicinal products with GMO

   CCMO’s website clarifies when CCMO is the designated review committee for certain types of research.

   News item | 18-05-2021 | 11:21

7. Clinical Trial Regulation to apply from January 31, 2022

   The European Medicines Agency (EMA) has confirmed that the development of the Clinical Trials Information System (CTIS) is on ...

   News item | 22-04-2021 | 16:28

8. Evaluation procedure VGO local feasibility started

   Since December 1, 2020, sponsors can choose whether to use the Site Suitability Declaration (Verklaring Geschiktheid ...

   News item | 30-03-2021 | 15:20

9. Clinical Trial Regulation expected to apply from January 31, 2022

   The European Medicines Agency (EMA) has announced a new expected go-live date of the Clinical Trials Information System (CTIS): ...

   News item | 18-03-2021 | 16:52

10. Risk inventory important for conduct of clinical research

    Yesterday, the cabinet declared a lockdown to reduce the spread of the coronavirus. In response to this, CCMO would like to draw ...

    News item | 15-12-2020 | 14:52